TOP GUIDELINES OF PEMBROLIZUMAB COST

Assessment Pembrolizumab (Keytruda): CADTH Reimbursement Suggestion: Indicator: In combination with chemotherapy, for that procedure of adult people with locally recurrent unresectable or metastatic triple-detrimental breast cancer which have not gained prior chemotherapy for metastatic disorder and whose tumours express programmed cell Loss of lif